4
Changes in Ownership
Oncotelic Therapeutics, Inc. Filed Acc 0001493152-26-003634
Options or other derivatives
- CHAIRMAN AND CEO acquired 4,426 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Trieu Vuong · CHAIRMAN AND CEO
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-01-22 | Grant or award : show line 1 in the form Series A Convertible Preferred Stock | +4,426 | 8,491 | D |
Loading xslF345X05/ownership.xml…